Three new customers launch iPLATO Patient Care Messaging

iPLATO announced today that it is launching three new Patient Care Messaging sites within three separate NHS Trusts in the London area. In the next few weeks selected patients of the Lambeth PCT, Hertsmere PCT and West London Mental Health Trust will start receiving automatic SMS reminders for their forthcoming outpatient appointments.


Callisto Pharmaceuticals, Inc. (Amex: KAL), a biopharmaceutical company focused on the development of drugs to treat cancer and osteolytic bone disease, announced today the completion of a private placement of approximately 1.99 million shares of its common stock at a per share price of $1.52, for aggregate gross proceeds of approximately $3.02 million.

24/7 intelligent monitoring for heart patients

Within a year a group of Spanish researchers are planning to market a remote cardiac monitoring system that has the potential to revolutionise healthcare for people with heart problems, granting them greater independence, peace of mind and quality of life.

New Program Addresses Sexuality During Menopause

New Nutritional Program - SexyMenopause - Helps the Menopausal Woman "Enjoy the Sexiest Time of Her Life." This program includes four specially packaged supplements that support sexual vitality, higher bone density, symptom-free bodies and clearer thinking

Empowering patients to lead fully mobile lives

High risk and chronically ill patients in Europe may soon find themselves able to lead independent and fully mobile lives thanks to the work of a project that has developed a Body Area Network of wireless sensors to remotely monitor vital signs.

Aethlon Scientist to Present Strategy for Treating Drug Resistant HIV and Hepatitis-C

Aethlon Medical, Inc. (OTCBB: AEMD) announced that its Chief Scientific Officer, Dr. Richard Tullis will present today at the 25th Annual Dialysis Conference, being held at the Tampa Convention Center. The presentation is scheduled to begin at 3:00 p.m. EST. Dr. Tullis will discuss how the multi-pathogen, multi-strain clearance characteristics of the Aethlon Hemopurifier(TM) could provide new hope for individuals afflicted with drug or vaccine resistant viral infections, including HIV, the AIDS virus, and Hepatitis-C.


Diary notice - 1.5 million people in the UK have a learning disability, which affects intellectual and social development throughout their lives. Yet many of the general public are unclear about the term learning disability. Learning Disability Week aims to raise awareness of what it means to have a learning disability.

POP = Put On Protection

Over 60% of the people who will be diagnosed with skin cancer in 2005 could have avoided the disease if they had practiced a safer sun protection regimen.